Artificial Intelligence (AI) is transforming industries, and drug development is no exception. The regulatory lifecycle, a critical part of therapeutic drug development, offers numerous opportunities for AI to streamline processes, reduce errors, and accelerate time to market.How do you effectively incorporate AI into this complex lifecycle? It requires a thoughtful approach and a clear framework to ensure success, which we present here as five key elements.